The authors underline the dysendocrine picture, typical of post-menopausal patients affected with endometrial cancer; based on actual data, they hypothesize the usefulness of a complementary tamoxifen treatment in this malignancy, as the drug proved able to lower prolactin and estradiol plasma levels.
Tamoxifen in the therapy of postmenopausal endometrial cancer: variations in some hormonal parameters
MOZZANEGA, BRUNO;
1980
Abstract
The authors underline the dysendocrine picture, typical of post-menopausal patients affected with endometrial cancer; based on actual data, they hypothesize the usefulness of a complementary tamoxifen treatment in this malignancy, as the drug proved able to lower prolactin and estradiol plasma levels.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
